相关实验视频

Updated: Jun 8, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

464

在B细胞淋巴瘤中应用CAR-T细胞疗法:随机对照试验的元分析

Xiao-Jing Yu1,2, Chang Liu2, Shi-Zhi Hu1

  • 1Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|November 8, 2024
PubMed
概括

化学抗原受体T细胞 (CAR-T) 免疫疗法显示B细胞淋巴瘤的缓解率高于标准治疗. 然而,CAR-T疗法增加了细胞因子释放综合征 (CRS) 和神经毒性 (NT) 的风险,这表明剂量优化可能会减轻这些不良事件.

关键词:
不良反应不良反应在B细胞淋巴瘤.在CAR-T细胞免疫疗法中.有效性 有效性.进行元分析分析.

更多相关视频

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.7K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.2K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480